Clinical Trial Update: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

View source ↗

Summary

A clinical trial evaluating allogeneic virus-specific cytotoxic T-lymphocytes for persistent or recurrent EBV, CMV, and adenoviral infections after hematopoieti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Allogeneic virus-specific cytotoxic T-lymphocytes (virus-specific cytotoxic T-lymphocytes)

Snippet

Sponsor: Baylor College of Medicine | Conditions: EBV Infection, CMV Infection | Status: NO_LONGER_AVAILABLE